Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

12.13
Delayed Data
As of Oct 20
 -0.35 / -2.80%
Today’s Change
8.31
Today|||52-Week Range
24.30
-16.46%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Pershing Square Capital Management Lp
Director
Sale3/13/201718,114,432$11.00$199.3M+0.17%
Valueact Capital Management Lp
Director
Buy3/14/20172,500,000$10.81$27.0M+11.39%
Valueact Capital Management Lp
Director
Buy3/14/2017500,000$10.88$5.4M+11.39%
Kellen Ari S
Chairman
Sale12/05/201619,932$18.00$358.8K-20.93%
De Schutter Richard U
Director
Buy5/11/201720,000$13.90$278.0K-12.10%
Rosiello Robert L
Executive VP-Corporate Development & Strategy
Sale12/05/201614,687$18.00$264.4K-20.93%
Herendeen Paul S
Chief Financial Officer & Executive Vice President
Buy3/14/201724,000$10.72$257.3K+11.39%
Herendeen Paul S
Chief Financial Officer & Executive Vice President
Sale8/23/201717,175$14.14$242.9K-15.88%
De Schutter Richard U
Director
Gift1/03/201711,190$15.24$170.5K-20.41%
Whitaker Anne Clem
Chairman
Sale12/05/20166,012$18.00$108.2K-20.93%
Page of 6